首页GNGBF • OTCMKTS
add
洁定
市场资讯
财务信息
损益表
收入
净收入
(SEK) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 78.70亿 | 3.46% |
经营支出 | 32.17亿 | 22.88% |
净收入 | 200.00万 | -99.78% |
净利润率 | 0.03 | -99.74% |
每股收益 | 2.24 | -15.79% |
息税折旧摊销前利润 | 6.26亿 | -50.51% |
有效税率 | 72.73% | — |
资产负债表
总资产
负债总额
(SEK) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 22.41亿 | -58.01% |
总资产 | 596.14亿 | 11.34% |
负债总额 | 291.47亿 | 35.42% |
权益总额 | 304.67亿 | — |
发行在外的股份 | 2.72亿 | — |
市净率 | 0.15 | — |
资产回报率 | 1.47% | — |
资本回报率 | 2.07% | — |
现金流
现金净变动
(SEK) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | 200.00万 | -99.78% |
来自运营的现金 | 6.80亿 | -51.81% |
投资现金 | -31.11亿 | -729.60% |
融资现金 | 23.57亿 | 1,563.98% |
现金净变动 | -4500.00万 | -104.98% |
自由现金流 | 20.50亿 | 198.82% |
简介
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. The company was formerly organised in three business areas: Infection Control, Extended Care and Medical Systems, but announced it would become a single brand company, operating under the brand Getinge, on 20 March 2017.
In 1989, it was acquired by Rune Andersson and Carl Bennet. Getinge’s stocks have been noted on the Stockholm stock exchange since 1993 and have been part of the OMXS30 Index since July 2009.
The company's president and CEO is Mattias Perjos. Johan Malmquist is the company's chairman. Getinge's shares have been listed on the OMX Nordic List in Stockholm since 1993 and have formed part of the OMXS30 index since July 2009. In 2011 Getinge acquired the US company Atrium Medical and in 2014 Pulsion Medical Systems. Wikipedia
成立时间
1904
员工数量
11,848